Jon Kessler - 16 Sep 2024 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jon Kessler
Issuer symbol
HQY
Transactions as of
16 Sep 2024
Net transactions value
-$2,332,993
Form type
4
Filing time
18 Sep 2024, 16:32:59 UTC
Previous filing
26 Jun 2024
Next filing
04 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Sale $1,357,808 -17,338 -7.7% $78.31 208,163 16 Sep 2024 Direct F1, F2
transaction HQY Common Stock Sale $288,988 -3,661 -1.8% $78.94 204,502 16 Sep 2024 Direct F1, F3
transaction HQY Common Stock Sale $566,929 -7,239 -6.6% $78.32 102,746 16 Sep 2024 by GKF, LLC F1, F4, F5
transaction HQY Common Stock Sale $119,268 -1,511 -1.5% $78.93 101,235 16 Sep 2024 by GKF, LLC F1, F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 17,409 16 Sep 2024 Common Stock 17,409 $41.28 Direct F6
holding HQY Stock Option (right to buy) 23,929 16 Sep 2024 Common Stock 23,929 $61.72 Direct F6
holding HQY Stock Option (right to buy) 38,343 16 Sep 2024 Common Stock 38,343 $73.61 Direct F6
holding HQY Stock Option (right to buy) 34,820 16 Sep 2024 Common Stock 34,820 $41.28 by GKF, LLC F6
holding HQY Stock Option (right to buy) 23,930 16 Sep 2024 Common Stock 23,930 $61.72 by GKF, LLC F6
holding HQY Stock Option (right to buy) 12,782 16 Sep 2024 Common Stock 12,782 $73.61 by GKF, LLC F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2,3,and 4) of this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.825 to $79.15, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.82, inclusive.
F5 These securities are held by the GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F6 The option is immediately exercisable.